We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.51B
AUM Growth
+$540M
Cap. Flow
-$18.6M
Cap. Flow %
-0.34%
Top 10 Hldgs %
46.25%
Holding
691
New
31
Increased
112
Reduced
426
Closed
60

Top Buys

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$33.3M
2
BE icon
Bloom Energy
BE
+$30.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$25M
4
SNDK
Sandisk
SNDK
+$23.5M
5
NBIS
Nebius Group N.V.
NBIS
+$22.4M

Top Sells

Rank Stock Value
1
BTI icon
British American Tobacco
BTI
+$36.2M
2
CLS icon
Celestica
CLS
+$21.9M
3
WMT icon
Walmart Inc
WMT
+$21.5M
4
UNH icon
UnitedHealth
UNH
+$20.7M
5
YUMC icon
Yum China
YUMC
+$14.8M

Sector Composition

Rank Sector Weight
1 Technology 48.98%
2 Communication Services 15.81%
3 Consumer Discretionary 13.07%
4 Healthcare 6.06%
5 Consumer Staples 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANAB icon
501
AnaptysBio
ANAB
$1.54B
$18.4K ﹤0.01%
602
-177
-23% -$4.06K
XNCR icon
502
Xencor
XNCR
$1.45B
$18K ﹤0.01%
1,534
-257
-14% -$2.23K
PHAT icon
503
Phathom Pharmaceuticals
PHAT
$928M
$18K ﹤0.01%
1,526
-225
-13% -$2.32K
PAHC icon
504
Phibro Animal Health
PAHC
$1.5B
$17.9K ﹤0.01%
443
-77
-15% -$2.54K
AIV
505
Aimco
AIV
$377M
$17.9K ﹤0.01%
2,257
-167
-7% -$1.36K
HPP
506
Hudson Pacific Properties
HPP
$758M
$17.7K ﹤0.01%
+914
New +$17.2K
VIR icon
507
Vir Biotechnology
VIR
$1.46B
$17.1K ﹤0.01%
2,989
-537
-15% -$2.75K
IOVA icon
508
Iovance Biotherapeutics
IOVA
$2.04B
$16.9K ﹤0.01%
7,785
-20
-0.3% -$47
KURA icon
509
Kura Oncology
KURA
$793M
$16.5K ﹤0.01%
1,867
-124
-6% -$884
CSR
510
Centerspace
CSR
$952M
$16.5K ﹤0.01%
280
-21
-7% -$1.21K
FTRE icon
511
Fortrea Holdings
FTRE
$1.93B
$16.5K ﹤0.01%
1,954
-342
-15% -$2.62K
AVXL icon
512
Anavex Life Sciences
AVXL
$231M
$16.4K ﹤0.01%
1,848
-323
-15% -$3.28K
MESO
513
Mesoblast
MESO
$1.83B
$16.4K ﹤0.01%
1,016
+199
+24% +$2.91K
AAT
514
American Assets Trust
AAT
$1.46B
$16.4K ﹤0.01%
805
-68
-8% -$1.37K
DEA
515
Easterly Government Properties
DEA
$1.16B
$16.3K ﹤0.01%
710
-16
-2% -$364
AVBP icon
516
ArriVent BioPharma
AVBP
$1.4B
$16.1K ﹤0.01%
873
+10
+1% +$196
TYRA icon
517
Tyra Biosciences
TYRA
$1.85B
$16K ﹤0.01%
1,147
-149
-11% -$1.7K
TBPH icon
518
Theravance Biopharma
TBPH
$873M
$15.8K ﹤0.01%
1,083
-175
-14% -$2.21K
PLYM
519
DELISTED
Plymouth Industrial REIT
PLYM
$15.7K ﹤0.01%
704
-28
-4% -$514
DAWN
520
DELISTED
Day One Biopharmaceuticals
DAWN
$15.5K ﹤0.01%
2,204
-378
-15% -$2.6K
ORKA
521
Oruka Therapeutics
ORKA
$5.31B
$15.5K ﹤0.01%
806
-90
-10% -$1.33K
NRIX icon
522
Nurix Therapeutics
NRIX
$2.45B
$15.2K ﹤0.01%
1,645
-169
-9% -$1.75K
AQST icon
523
Aquestive Therapeutics
AQST
$452M
$14.6K ﹤0.01%
2,603
+341
+15% +$1.47K
OLMA icon
524
Olema Pharmaceuticals
OLMA
$977M
$14.5K ﹤0.01%
1,477
+55
+4% +$330
MGTX icon
525
MeiraGTx Holdings
MGTX
$1.08B
$14.2K ﹤0.01%
1,731
-270
-13% -$2.13K
19 20
21
22 23

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q3 2025 Portfolio in Review

As of Q3 2025, GF Fund Management held 691 positions worth $5.51B, up 11% from $4.97B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

GF Fund Management's Q3 2025 filing shows 31 new, 112 increased, 426 reduced and 60 closed positions. Its largest new stake was Bloom Energy: 648,856 shares worth $54.9M. The largest sale was British American Tobacco, an estimated $36.2M.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 46% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q3 2025 buy was Bloom Energy: 648,856 shares worth $54.9M.
  • GF Fund Management added most to Lumentum in Q3 2025, an estimated $33.3M increase.
  • GF Fund Management's biggest Q3 2025 reduction was British American Tobacco, cutting an estimated $36.2M.
  • GF Fund Management fully exited Yum China in Q3 2025, selling an estimated $14.8M.
  • GF Fund Management's ten largest holdings make up 46% of its $5.51B portfolio in Q3 2025.
  • GF Fund Management opened 31 new positions and closed 60 in Q3 2025.
  • GF Fund Management's portfolio value rose 11% quarter-over-quarter to $5.51B.

Based on GF Fund Management's 13F filing for Q3 2025, filed 7 Nov 2025.